About Providence Therapeutics
Providence Therapeutics is a clinical-stage mRNA platform company developing vaccines for cancers and infectious diseases. Our scalable, efficient platform demonstrates differentiated capabilities in mRNA design, manufacturing, and formulation processes, as well as specific organ and tissue targeting. We are building a portfolio of oncology vaccines while advancing a coronavirus vaccine candidate. Additionally, we’re pursuing vaccine programs for infectious diseases that pose public health risks, including influenza and rabies. For more information, please visit providencetherapeutics.com.
|
|
|
51-200 employees
View all Providence Therapeutics employees
|
|
Biotechnology Research
|
|
$10M–$50M
|
|
+1 416-123-4567
|
|
120, 8832 Blackfoot Trail, Calgary, Alberta T2J 3J1, CA
|
|
2015
|
|
Biotech, Cancer Vaccines, Mrna Therapeutics, Lipid Nanoparticles, Covid-19 Vaccine, Personalized Vaccines
|
Providence Therapeutics Alternatives
Frequently Asked Questions about Providence Therapeutics
Bradley Sorenson is the CEO of Providence Therapeutics. To contact Bradley Sorenson email at [email protected].
The decision makers in Providence Therapeutics are Eric Marcusson, Jay Yoo, Jennifer Bryan, etc. Click to Find Providence Therapeutics decision makers emails.
Providence Therapeutics headquarters is located at 120, 8832 Blackfoot Trail, Calgary, Alberta T2J 3J1, CA.
Providence Therapeutics generates an estimated $10M–$50M annually, based on industry analysis and publicly available market data.
You can contact Providence Therapeutics by calling +1 416-123-4567.
Providence Therapeutics Staff Directory
Search Providence Therapeutics Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
